Details of the Drug Reposition

General Information of This Drug (ID: DMX2TEM)

• Drug Name: LOR-2040 (DMX2TEM)

Information on Drug Reposition of This Drug

5 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 2	[1]
Metastatic colorectal cancer	DIS18R3K	2B91	Phase 2	[1]
Breast cancer	DIS7DPX1	2C60-2C65	Phase 2	[1]
Prostate cancer	DISF190Y	2C82.0	Phase 2	[1]
Metastatic renal cancer	DISZOZRY	2D50	Phase 2	[1]

References

• [1] ClinicalTrials.gov (NCT00087165) GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer. U.S. National Institutes of Health.